Is DEHP (CAS 117-81-7) on the REACH Authorisation List (Annex XIV), and what latest application date and sunset date apply to its use in medical devices under the MDR and IVDR?

Yes. DEHP (EC 204-211-0, CAS 117-81-7) is entry 4 on the REACH Authorisation List (Annex XIV). For uses in medical devices within the scope of the MDR (EU) 2017/745 and IVDR (EU) 2017/746, the latest application date is 1 January 2029 and the sunset date is 1 July 2030 ^[1].

Approach: I checked ECHA's Authorisation List and the Annex XIV entry in the current consolidated REACH Regulation (consolidated version of 11 May 2026).

What the entry says

^[1]

• Reasons for listing: Toxic for reproduction (Cat. 1B), plus endocrine-disrupting properties under Article 57(f) for both human health and the environment ^[1].
• Where the dates come from: ECHA's Authorisation List entry only shows the general dates (21 August 2013 and 21 February 2015). The medical-device dates are in the consolidated legal text. ECHA links the entry to two amending regulations: Regulation (EU) 2021/2045 and the original listing, Regulation (EU) No 143/2011 ^[2].
• What this means for devices: If you want to keep using DEHP in a device after 1 July 2030, you need an authorisation. To keep supplying while your application is being decided, it must be submitted by 1 January 2029 ^[1].

I can look up the existing Commission authorisation decisions or RAC/SEAC opinions for DEHP uses next, if that would help.